Skip to content

BURZYNSKI RESEARCH INSTITUTE INC: 10-Q filed 2024-01-16

What BURZYNSKI RESEARCH INSTITUTE INC reported in its quarterly report filed 2024-01-16 (fiscal Q3 2024): 26 published measures, 85 facts as tagged in accession 0001558370-24-000294.

This filing

Form
10-Q (quarterly report)
Filed
2024-01-16
Fiscal period
fiscal Q3 2024
Accession
0001558370-24-000294 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BURZYNSKI RESEARCH INSTITUTE INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-11-301,013USD
At 2023-02-281,934USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-11-3035,847USD
At 2023-02-2815,661USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-11-30-34,834USD
At 2023-08-31-4,476USD
At 2023-05-31-70,518USD
At 2023-02-28-13,727USD
At 2022-11-30-26,628USD
At 2022-08-31-13,638USD
At 2022-05-31-38,680USD
At 2022-02-281,206USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-11-30913USD
At 2023-02-28934USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-09-01 to 2023-11-30-433,015USD91
2023-03-01 to 2023-11-30-972,524USD275
2023-06-01 to 2023-08-31-252,104USD92
2023-03-01 to 2023-05-31-287,405USD92
2022-09-01 to 2022-11-30-252,639USD91
2022-03-01 to 2022-11-30-700,294USD275
2022-06-01 to 2022-08-31-215,918USD92
2022-03-01 to 2022-05-31-231,737USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-03-01 to 2023-11-30-386,160USD275
2022-03-01 to 2022-11-30-176,241USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-03-01 to 2023-11-30386,139USD275
2022-03-01 to 2022-11-30174,551USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-11-30-127,727,299USD
At 2023-02-28-126,754,775USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-09-01 to 2023-11-30131,448,444shares91
2023-03-01 to 2023-11-30131,448,444shares275
2022-09-01 to 2022-11-30131,448,444shares91
2022-03-01 to 2022-11-30131,448,444shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-09-01 to 2023-11-30131,448,444shares91
2023-03-01 to 2023-11-30131,448,444shares275
2022-09-01 to 2022-11-30131,448,444shares91
2022-03-01 to 2022-11-30131,448,444shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-09-01 to 2023-11-300USD/shares91
2023-03-01 to 2023-11-30-0.01USD/shares275
2022-09-01 to 2022-11-300USD/shares91
2022-03-01 to 2022-11-30-0.01USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-09-01 to 2023-11-300USD/shares91
2023-03-01 to 2023-11-30-0.01USD/shares275
2022-09-01 to 2022-11-300USD/shares91
2022-03-01 to 2022-11-30-0.01USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-09-01 to 2023-11-300USD91
2023-03-01 to 2023-11-300USD275
2022-09-01 to 2022-11-300USD91
2022-03-01 to 2022-11-300USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-09-01 to 2023-11-30-433,015USD91
2023-03-01 to 2023-11-30-972,524USD275
2022-09-01 to 2022-11-30-252,639USD91
2022-03-01 to 2022-11-30-700,294USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-11-301,013USD
At 2023-02-281,934USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-11-3020,000USD
At 2023-02-2812,570USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-09-01 to 2023-11-30433,015USD91
2023-03-01 to 2023-11-30972,524USD275
2022-09-01 to 2022-11-30252,639USD91
2022-03-01 to 2022-11-30700,294USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-09-01 to 2023-11-30218,069USD91
2023-03-01 to 2023-11-30614,240USD275
2022-09-01 to 2022-11-30207,651USD91
2022-03-01 to 2022-11-30545,960USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-11-30131,448,444shares
At 2023-02-28131,448,444shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-11-30913USD
At 2023-02-28934USD
At 2022-11-301,692USD
At 2022-02-283,382USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-11-3015,847USD
At 2023-02-283,091USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2023-11-300USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-09-01 to 2023-11-30-433,015USD91
2023-03-01 to 2023-11-30-972,524USD275
2022-09-01 to 2022-11-30-252,639USD91
2022-03-01 to 2022-11-30-700,294USD275

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-03-01 to 2023-11-30-972,524USD275
2022-03-01 to 2022-11-30-700,294USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-09-01 to 2023-11-30214,946USD91
2023-03-01 to 2023-11-30358,284USD275
2022-09-01 to 2022-11-3044,988USD91
2022-03-01 to 2022-11-30154,334USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-03-01 to 2023-11-307,430USD275
2022-03-01 to 2022-11-3016,650USD275

Inspect the source

Entity
BURZYNSKI RESEARCH INSTITUTE INC / CIK 0000724445
Captured
2026-09-19T15:00:09.958Z
SEC response SHA-256
280fe93908eb6d3bca8df7351a6ce86b0d12e15fb5a41d56bd44784f717cff04

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000724445.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))